Department of Radiation Oncology

Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution Reirradiation of recurent glioblastomas: High prognostic significance of contrast-enhancing tumor volume (2021) Mansoorian S, Coras R, Weissmann T, Lettmaier S, Semrau S, Frey B, Bert C, et al. Conference contribution Cell-Cannibalism by Normal Tissue Cells as a Survival Benefit after Irradiation of Normal Tissue Cells leads to an Increase in their Activity as non-professional Phagocytes (2021) Sonntag T, Distel L, Fietkau R Conference contribution App for the Early Detection of Side Effects of Immunotherapy (2021) Goldbrunner L, Hecht M, Fietkau R, Distel L Conference contribution The IMMO-LDRT01 Study - Analgesic and immunomodulatory Effects of LDRT in Patients with chronic degenerative and inflammatory Diseases (2021) Donaubauer AJ, Fröhlich B, Becker I, Weissmann T, Fietkau R, Ott O, Gaipl U, Frey B Conference contribution Website on the individual Radiation Sensitivity of Tumor Patients (2021) Rzepka D, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes to generate Cell-in-Cell Structures (2021) Hofmann A, Fietkau R, Distel L Conference contribution Tumor-infiltrating Memory T Cells in Head and Neck Tumors: An ambivalent prognostic Factor (2021) Hartan R, Schnellhardt S, Büttner-Herold M, Daniel C, Fietkau R, Distel L Conference contribution Expression of Immune Phenotypes in Rectal Cancer after neoadjuvant Chemoradiotherapy (2021) Schnellhardt S, Hirneth J, Büttner-Herold M, Daniel C, Fietkau R, Distel L Conference contribution Evaluation of a dedicated Treatment Planning-MRI for Patients with cranial Stereotaxy (2021) Grigo J, Masitho S, Putz F, Fietkau R, Bert C Conference contribution